Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial




Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Grazia Franzosi M, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ, on behalf of the RE-LY investigators, Airaksinen J

2010

Lancet

9745

376

9745

975

983

9

0140-6736

DOIhttps://doi.org/10.1016/S0140-6736(10)61194-4(external)




Last updated on 2024-26-11 at 23:40